TCL Archive Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer November 28, 2014
TCL Archive Scientists Tell Panel: Peer Review Need Improving, Available Funds Should Be Spread Over More Grants April 30, 1982